Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 489201 - 489220 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 3MG TAB | 84 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 3MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 3MG TAB | 84 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 4MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 4MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 4MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 4MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 5MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN01) erdafitinib (adm: O) | BALVERSA 5MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Urologic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EN04) futibatinib | LYTGOBI 4MG X 3 (12MG) DAILY PKT,21 | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | TaihoOncology,Inc. |
| USA | (L01EN04) futibatinib | LYTGOBI 4MG X 4 (16MG) DAILY PKT,28 | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | TaihoOncology,Inc. |
| USA | (L01EN04) futibatinib | LYTGOBI 4MG X 5 (20MG) DAILY PKT,35 | 35 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | TaihoOncology,Inc. |
| USA | (L01EX) other protein kinase inhibitors | RETEVMO 40MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX) other protein kinase inhibitors | RETEVMO 40MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX) other protein kinase inhibitors | RETEVMO 80MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX) other protein kinase inhibitors | RETEVMO 80MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX) other protein kinase inhibitors | RETEVMO 80MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX) other protein kinase inhibitors | RETEVMO 80MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX03) pazopanib (adm: O) | PAZOPANIB 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AvKare,LLC |
| USA | (L01EX03) pazopanib (adm: O) | VOTRIENT 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | NovartisPharmaceuticalsCorporation |
Pages
